Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US industry convenes meeting on FDA's post-market safety progress:

This article was originally published in Clinica

Executive Summary

AdvaMed has scheduled a two-day meeting in Bethesda, next month, on the FDA's post-market safety activities. Association officials said the meeting is intended to be a follow-up to a meeting last September on post-market issues involving implantable cardioverter defibrillators and pacemakers. That meeting was organised by the Heart Rhythm Society in the wake of a series of high-profile ICD recalls that led to heightened scrutiny of the industry. The upcoming workshop is scheduled for February 8-9. "It will set the stage for collaboration process improvement initiatives," AdvaMed said, and will be the first in a series of joint post-market workshops with the agency.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050625

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel